Fierce Pharma
JULY 12, 2024
Trials have already shown that Novo Nordisk’s semaglutide | Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.
pharmaphorum
JULY 12, 2024
A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 12, 2024
Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the future—despite a few promising growth opportunities the team has identified. | Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the drugmaker—despite a few promising growth opportunities they identified.
Pharmaceutical Technology
JULY 12, 2024
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JULY 12, 2024
Even through an onslaught of biosimilar launches that began early last year, AbbVie’s big-selling Humira has been able to retain most of its lucrative market. | With ten biosimilar options in play, AbbVie's star immunology drug lost 13% of its total market share since March, according to a new Samsung Bioepis report.
MedCity News
JULY 12, 2024
This week, HHS issued its HTI-2 proposal — a new proposed rule to improve healthcare data sharing among providers, payers, patients and public health organizations. It comes just seven months after HHS issued its HTI-1 rule. The post What’s Included In HHS’ New Interoperability Proposal? appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JULY 12, 2024
Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round
MedCity News
JULY 12, 2024
Like in every other industry, AI is knocking on the doors of healthcare with solutions that promise to revolutionize delivery of care. Advancing from a pen-and-paper mindset to a digital revolution will require the use of bridge technology. The post Cultural Challenges to the Much-Needed Digital Revolution in Healthcare Supply Chain Management appeared first on MedCity News.
PharmaVoice
JULY 12, 2024
Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.
MedCity News
JULY 12, 2024
The FDA rejected Novo Nordisk’s biologics license application for icodec, citing questions about the manufacturing process for this once weekly insulin as well as its use by type 1 diabetes patients. But there are several high-profile FDA approvals in our recap of recent regulatory news. The post FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JULY 12, 2024
New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it
MedCity News
JULY 12, 2024
The roster of speakers at INVEST Digital Health scheduled for September 18 in Dallas includes executives from health systems, healthcare entrepreneurs, and more. Register today! The post Check Out the Roster of Healthcare Innovators Taking Part in INVEST Digital Health in Dallas appeared first on MedCity News.
Pharmaceutical Commerce
JULY 12, 2024
The latest news for pharma industry insiders.
MedCity News
JULY 12, 2024
Through a new partnership, Cityblock will offer medical and behavioral health services to members with serious mental illness or substance use disorder in Alliance Health’s Behavioral Health and Intellectual/Development Disability Tailored Plan. The post Cityblock, Alliance Health Launch Medicaid Partnership in North Carolina appeared first on MedCity News.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
JULY 12, 2024
Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.
MedCity News
JULY 12, 2024
The Procurement Maturity Model is more than just a self-assessment tool; it’s an invitation to transform. The post Unlocking Hidden Value: Navigating Healthcare Procurement Maturity appeared first on MedCity News.
PharmaTimes
JULY 12, 2024
The progressive neurodegenerative disease affects more than 55 million people globally
Pharmaceutical Technology
JULY 12, 2024
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.
PharmaTimes
JULY 12, 2024
The awards celebrated both medical affairs and nursing professionals in the industry
Pharmaceutical Commerce
JULY 12, 2024
Why they are a game changer, and ways to a adapt to a new era of state privacy regulations.
PharmaTimes
JULY 12, 2024
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally
Pharmaceutical Technology
JULY 12, 2024
The cash injection will accelerate the development of Crossject’s prefilled needle free platform to treat anaphylactic shock.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
JULY 12, 2024
Helping patients overcome barriers to accessing these treatments is a vital role for pharmacists, who can support patients who are looking to quit.
Pharmaceutical Technology
JULY 12, 2024
Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.
Pharmacy Times
JULY 12, 2024
Results show that daily injections of buprenorphine over a 7-day period was safe and well-tolerated in patients who had Clinical Opioid Withdrawal Scale scores of 4 to 7.
Nixon Gwilt Law
JULY 12, 2024
The 2025 Medicare Physician Fee Schedule Proposed Rule (the “2025 Proposed Rule”) issued by the Centers for Medicare and Medicaid Services (or “CMS”) on July 10, 2024 contains a number of new policy proposals with significant implications for healthcare innovators. Below is an overview of the most important proposals and the opportunities they present for healthcare innovators and digital health companies.
Pharmacy Times
JULY 12, 2024
Unique gut flora were found in children with autism spectrum disorder (ASD).
Scott’s Directories
JULY 12, 2024
In Manitoba, the healthcare sector thrives, offering vast market opportunities. For businesses targeting this industry, access to a comprehensive physician directory in Manitoba is invaluable. Whether you’re a pharmaceutical company, a medical equipment supplier, or a healthcare recruiter, having a detailed Manitoba medical directory can significantly enhance your outreach efforts.
Pharmaceutical Commerce
JULY 12, 2024
The acquisition in the ophthalmology space features a $1.3 billon cash payment, with the potential for an additional $1.7 billion if various milestones are met.
Scott’s Directories
JULY 12, 2024
In the dynamic world of pharmaceutical sales, having access to accurate and comprehensive information is crucial. One of the most valuable resources available to sales professionals is MD Select’s BC Doctors Directory. This directory provides detailed information on physicians across British Columbia, enabling sales teams to target their efforts more effectively.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
321 
Let's personalize your content